[Summary of work session 1: Blood coagulation in gastroenterology].
Part I: Immunological assays of clotting factors in the diagnosis of liver diseases. The immunological determination of Antithrombin III is a good measure of the capacity of the liver to synthesize plasma proteins. Antithrombin III concentration in serum correlated significantly with the prothrombin time and the activity of cholinesterase. The immunological determination of factor VIII related antigen seems to be important for the early recognition of the transition of an acute hepatitis into a chronic course. While following uncomplicated acute hepatitis the level of factor VIII related antigen is normal after 40 weeks, it remains high in cases which become chronic. Immunological assay of factor XIII seems to be not very useful in the diagnosis of liver diseases. Part II: Management of coagulation disturbances in liver diseases. Except cases of hepatic coma the hemostatic abnormalities in chronic liver diseases are rarely severe enough that correction is necessary. Prothrombin concentrates are considered by most of the discussants as unnecessary and potentially dangerous. Transfusion of platelets is only neccessary when the platelet count is below 40.000 and surgery is planned. It is uncertain whether patients with chronical liver disease and laboratory signs of DIC benefit from heparin therapy. Although laboratory tests may be improved, prognosis, especially in cases of acute oesophageal bleeding, seems to be not changed by this treatment.
D000991:Antithrombins / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000032:analysis*; D001792:Blood Platelets; D001803:Blood Transfusion; D005169:Factor VIII / Q000032:analysis; D005176:Factor XIII / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use; D006505:Hepatitis / Q000097:blood; D006801:Humans; D007158:Immunologic Techniques; D008103:Liver Cirrhosis / Q000097:blood; D008107:Liver Diseases / Q000097:blood* / Q000188:drug therapy; D011516:Prothrombin / Q000627:therapeutic use
D000991:Antithrombins; D001779:Blood Coagulation Factors; D011516:Prothrombin; D005169:Factor VIII; D006493:Heparin; D005176:Factor XIII
Zusammenfassung der Arbeitssitzung I Blutgerinnung in der Gastroenterologie